Ritzim OL Cefixime Ofloxacin Lactic Acid Bacillus Tablets, 400 mg

₹ 1,900/Box

Strength400 mg
Form Of MedicinesTablets
Packaging TypeStrips
Medicine TypeAllopathic
Packaging Size10x10 Tablets
BrandRitzim OL
CompositionCefixime,Ofloxacin and Lactic Acid Bacillus
Prescription/Non prescriptionPrescription
AvailabilityIn Stock

We are listed to be one of the noteworthy names for this impeccable selection of Ritzim OL Tablet at very affordable rates.

Find products similar to Ritzim OL Cefixime Ofloxacin Lactic Acid Bacillus Tablets, 400 Mg

Find related categories

Shipping Information

PriceExcluding all taxes
Ships fromKanpur
ShippingAs per delivery location

Product Image

Ritzim OL Cefixime Ofloxacin Lactic Acid Bacillus Tablets, 400 mg image 1Ritzim OL Cefixime Ofloxacin Lactic Acid Bacillus Tablets, 400 mg image 2Ritzim OL Cefixime Ofloxacin Lactic Acid Bacillus Tablets, 400 mg image 3

About the Company

GST Registration Date
Jul 2017
Legal Status of Firm
Proprietorship
Nature of Business
Trader - Wholesaler/Distributor
Number of Employees
Upto 10 People
Annual Turnover
40 L - 1.5 Cr
IndiaMART Member Since
Sept 2011
GST
09**********1ZZ
In today's fast-paced world, access to high-quality pharmaceutical products is vital for ensuring the well-being and longevity of individuals worldwide. Ukesia Pharmaceuticals, a leading player in the pharmaceutical industry, is committed to revolutionizing healthcare by providing innovative solutions and a diverse range of pharmaceutical products. With a strong focus on quality, reliability, and customer satisfaction, Ukesia Pharmaceuticals is a trusted partner for healthcare professionals, distributors, and patients alike. At the core of our endeavor to provide affordable and top-notch products lies our corporate culture and strong partnerships with development and manufacturing allies. We take pride in offering a diverse selection of superior medications across various critical treatment domains. As part of our overarching plan, we aim to enhance our array of off-patent blockbusters while simultaneously broadening our range of offerings in specific disease areas.